Scarica l'app Stockscreener
0.6291
0.00%
0.00
Precedente Chiudi:
$0.6291
Aprire:
$0.627
Volume 24 ore:
94,413
Relative Volume:
0.13
Capitalizzazione di mercato:
$4.25M
Reddito:
$72,100
Utile/perdita netta:
$-3.60M
Rapporto P/E:
-0.5287
EPS:
-1.19
Flusso di cassa netto:
$-3.37M
1 W Prestazione:
-0.36%
1M Prestazione:
+26.89%
6M Prestazione:
-36.33%
1 anno Prestazione:
-34.13%
Intervallo 1D:
$0.61
$0.63
Intervallo di 1 settimana:
$0.60
$0.6598
Portata 52W:
$0.4101
$4.50
Silo Pharma Inc Stock (SILO) Company Profile
Nome
Silo Pharma Inc
Settore
Industria
Telefono
(718) 400-9031
Indirizzo
677 N. WASHINGTON BLVD, SARASOTA
Confronta SILO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.375 | 544.73M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.57 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.143 | 316.76M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
2.79 | 118.42M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
2.00 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Borsa (SILO) Ultime notizie
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
SILO Pharma Secures USPTO Approval for Key Patent Enhancing SPC-15 Protection | SILO Stock News - GuruFocus
Silo Pharma receives patent allowance for PTSD treatment technology - Investing.com
Silo Pharma receives patent allowance for PTSD treatment technology By Investing.com - Investing.com Canada
Silo Pharma, Inc. Receives Notice of Allowance for Patent Strengthening SPC-15 Treatment for PTSD - Nasdaq
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears - GlobeNewswire
Breakthrough PTSD Drug Patent: Silo Pharma's Intranasal Treatment Advances Toward Clinical Trials - Stock Titan
Silo Pharma approves purchase of Bitcoin as treasury reserve asset; shares up - MSN
Silo Pharma allocates $1 million to Bitcoin holdings By Investing.com - Investing.com South Africa
Is Silo Pharma moving to BIO Protocol? No - Binance
Silo Pharma's Board Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset; Shares Rise - MarketScreener
Silo Pharma (SILO) Allocates $1 Million for Bitcoin Investment | - GuruFocus
Silo Pharma allocates $1 million to Bitcoin holdings - Investing.com
Silo Pharma stock surges on Bitcoin reserve move - Investing.com
Silo Pharma stock surges on Bitcoin reserve move By Investing.com - Investing.com South Africa
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset - The Manila Times
Silo Pharma, Inc. Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset - Nasdaq
Biotech Makes Bold Move: Silo Pharma Commits $1M to Bitcoin as Inflation Shield - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Benzinga
Silo Pharma's (NASDAQ:SILO) Groundbreaking Therapies Could Change The Treatment Landscape For PTSD, Fibromyalgia, MS & Alzheimer’s - simplywall.st
Silo Pharma advances PTSD treatment with new drug-device study By Investing.com - Investing.com South Africa
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15 - GlobeNewswire
Silo Pharma stock plunges to 52-week low of $0.47 By Investing.com - Investing.com Canada
Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug - Seeking Alpha
SiloPharma (SILO) Advances SPC-15 with New Drug-Device Study Agreement | SILO Stock News - GuruFocus
Silo Pharma Collaborates With Resyca for Drug-Device Study of PTSD Drug SPC-15 - marketscreener.com
Silo Pharma advances PTSD treatment with new drug-device study - Investing.com Australia
Breakthrough PTSD Treatment: Silo Pharma's Brain-Targeting Drug Delivery System Heads to FDA - Stock Titan
Silicon Valley - FinancialContent
Silo Pharma Announces Closing of $2 Million Public Offering - GlobeNewswire
Silo Pharma Completes Public Offering, Raises $1.56 Million - TipRanks
Silo Pharma, Inc. Completes Public Offering Raising Approximately $2 Million - Nasdaq
Silo Pharma Announces Closing Of $2 Million Public Offering - marketscreener.com
SEC Form 424B4 filed by Silo Pharma Inc. - Quantisnow
Silo Pharma sets public offering at $0.60 per share and warrant - Investing.com Nigeria
SiloPharma (SILO) Sets $2 Million Public Offering with Warrants - GuruFocus
Silo Pharma Announces Pricing of $2 Million Public Offering - The Manila Times
Silo Pharma, Inc. Prices Public Offering of 3,333,338 Shares with Associated Warrants - Nasdaq
Silo Pharma Announces $2M Offering with 5-Year Warrants: Complete Details of Latest Financing Round - Stock Titan
Silo Pharma advances in PTSD nasal therapy trials By Investing.com - Investing.com Canada
Silo Pharma Retail Buzz Surges On FDA Toxicology Study Plans For PTSD Treatment - Asianet Newsable
Silo Pharma (SILO) Partners with Veloxity Labs for Key Drug Stud - GuruFocus
Silo Pharma advances PTSD treatment study with Veloxity Labs By Investing.com - Investing.com Canada
Silo Pharma (SILO) Partners with Veloxity Labs for Key Drug Study | SILO Stock News - GuruFocus
Silo Pharma advances PTSD treatment study with Veloxity Labs - Investing.com Australia
Silo Pharma Inc Azioni (SILO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Silo Pharma Inc Azioni (SILO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Weisblum Eric | CEO and President |
Dec 13 '24 |
Buy |
0.84 |
2,500 |
2,097 |
187,932 |
| Weisblum Eric | CEO and President |
Nov 20 '24 |
Buy |
0.95 |
2,500 |
2,375 |
182,932 |
| Weisblum Eric | CEO and President |
Nov 22 '24 |
Buy |
0.90 |
2,500 |
2,250 |
185,432 |
0.34%
7.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):